
Spaxim S 250mg/125mg Injection
Marketer
TNT Lifesciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Spaxim S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. This medication combats microorganisms, inhibiting their proliferation and preventing infection spread. Administration of Combiflox 250mg/125mg Injection must be solely under a healthcare provider's direction. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire course of treatment, regardless of symptom improvement. Premature cessation may compromise the medication's effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician about all current medications prior to commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While it typically doesn't impair driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order blood tests and other investigations to assess the medication's impact on your system.
Uses of Spaxim S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Spaxim S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Spaxim S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Spaxim S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Spaxim S 250mg/125mg Injection works:
Spaxim S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counters bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of Spaxim S 250mg/125mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Spaxim S 250mg/125mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Spaxim S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Spaxim S 250mg/125mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Spaxim S 250mg/125mg Injection to individuals with impaired renal function is scarce. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Spaxim S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Spaxim S 250mg/125mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Spaxim S 250mg/125mg Injection :
Omit a Spaxim S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Spaxim S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Infectious Disease Treatments |
